DNA-Repair Defects and Olaparib in Metastatic Prostate CancerJoaquı́n Mateo, Johann S. de Bono, Emma Hall et al.|New England Journal of Medicine|2015Cited by 2.2k
Identification of a Disease-Defining Gene Fusion in Epithelioid HemangioendotheliomaMunir R. Tanas, Brian P. Rubin, Andrea Sboner et al.|Science Translational Medicine|2011Cited by 401
ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1AChris T. Williamson, Christopher J. Lord, Rowan Miller et al.|Nature Communications|2016Cited by 386
Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor SensitivityIlirjana Bajrami, Alan Ashworth, Christopher J. Lord et al.|Cancer Research|2013Cited by 367
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistenceJulia A. Belk, Ansuman T. Satpathy, Winnie Yao et al.|Cancer Cell|2022Cited by 347